Needham & Company Updates Ests on Arena Pharma (ARNA) Following Q3 Results; Maintains 'Hold' Rating
Tweet Send to a Friend
Needham & Company affirms Arena Pharma (Nasdaq: ARNA) at Hold following the company's Q3 reprot on Tuesday night.Analyst Alan Carr ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
